We are monitoring the impact of COVID-19 on Europe Intravenous Ibuprofen Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6503
Share on
Share on

Europe Intravenous Ibuprofen Market Research Report - Segmented By Age Group, By Indication & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts | 2019-2024

Pulished: February, 2020
ID: 6503
Pages: 145

Europe Intravenous Ibuprofen Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Intravenous Ibuprofen Market is valued at USD 1.82 billion in 2019 and estimated to be growing at a CAGR of 19.23%, to reach USD 4.38 billion by 2024 during the forecast period 2019-2024.

Ibuprofen is a Non-steroidal anti-Inflammatory drug used to treat pain and fever which can be causative of a disease, trauma or any major operation. In an intravenous form, the drug has a faster onset of action as compared to other forms. IV Ibuprofen is used to manage acute and post-operative pain.

Due to its faster onset of action and fast results, the market is expected to grow at a rapid rate during the forecast period. As it has been approved for paediatric use, the market is further expected to propel. Due to increased incidence of cardiovascular diseases, cancer and fever coupled with shifting trend to non-opoid drugs is further driving the market growth. However, the side effects associated with the use of ibuprofen and the lengthy approval processes are hampering the market growth.

This research report segmented and sub-segmented into the following categories:

  • By Age Group: adults and Paediatrics
  • By Indication: Fever and Pain/inflammatory
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe is predicted to grow at a substantial rate.

Key players operating in the Europe Intravenous Ibuprofen Market profiled in this report are Cumberland Pharmaceuticals Inc., Alveda Pharmaceuticals, Inc., CSL Limited, Sandor Medicaids Pvt Ltd., Germin MED, Grifols S.A., Harbin Gloria Pharmaceuticals Co., Ltd., Al Nabeel International Ltd., PT. Soho Industri Pharmasi, and Laboratorios Valmorca, C.A.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1          Age group                                          

                                5.1.1 Introduction                                           

                                5.1.2 Paediatrics                                              

                                5.1.3 Adults                                       

                                5.1.4  Y-o-Y Growth Analysis, By age group                                          

                                5.1.5  Market Attractiveness Analysis, By age group                                        

                                5.1.6  Market Share Analysis, By age group                                          

                5.2          Indication                                           

                                5.2.1 Introduction                                           

                                5.2.2 Pain/inflammatory                                              

                                5.2.3 Fever                                         

                                5.2.4 Y-o-Y Growth Analysis, By Indication                                           

                                5.2.5 Market Attractiveness Analysis, By Indication                                         

                                5.2.6 Market Share Analysis, By Indication                                           

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By age group                      

                                                6.1.3.3 By indication                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By age group                      

                                                6.1.4.3 By indication                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By age group                      

                                                6.1.5.3 By indication                       

                6.2 U.K                                                 

                6.3 Spain                                                             

                6.4 Germany                                                     

                6.5 Italy                                                               

                6.6 France                                                          

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Cumberland Pharmaceuticals Inc.                                                     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Alveda Pharmaceuticals, Inc.                                                              

                8.3 CSL Limited                                                 

                8.4 Sandor Medicaids Pvt Ltd.                                                    

                8.5 Germin MED                                                              

                8.6 Grifols S.A.                                                  

                8.7 Harbin Gloria Pharmaceuticals Co.Ltd.                                                            

                8.8 Al Nabeel International Ltd.                                                

                8.9 Laboratorios Valmorca, C.A.                                                

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Age group, by Indication along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Europe Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  2. Europe Paediatric Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Adults Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  5. Europe Pain/inflammatory Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Fever Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )
  8. Europe Supermarket and hypermarkets Market By Region, From 2019-2024 ( USD Billion )
  9. Europe Convenience stores Market By Region, From 2019-2024 ( USD Billion )
  10. Europe Specialty stores Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Online sale Market By Region, From 2019-2024 ( USD Billion )
  12. U.K. Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  13. U.K. Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  14. U.K. Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )
  15. Germany Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  16. Germany Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  17. Germany Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )
  18. France Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  19. France Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  20. France Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )
  21. Italy Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  22. Italy Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  23. Italy Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )
  24. Spain Intravenous Ibuprofen  Market By Age group, From 2019-2024 ( USD Billion )
  25. Spain Intravenous Ibuprofen  Market By Indication, From 2019-2024 ( USD Billion )
  26. Spain Intravenous Ibuprofen  Market By Distribution channel, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample